Side-by-side comparison of AI visibility scores, market position, and capabilities
Telehealth opioid use disorder treatment with buprenorphine prescribing; removing geographic barriers to MAT for patients in 20+ states through online clinical visits.
Ophelia is a telehealth platform specializing in medication-assisted treatment (MAT) for opioid use disorder, providing access to buprenorphine (Suboxone) through online consultations and prescription management for patients across the United States. Founded in 2019 and headquartered in New York City, Ophelia addresses the severe treatment access gap in opioid addiction care — where millions of Americans with opioid use disorder cannot access MAT due to provider shortages, geographic barriers, stigma, or cost.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.